MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $107,250,470 | +4.4% | 2,462,132 | -13.4% | 0.01% | +10.0% |
| Q2 2023 | $102,770,774 | +34.7% | 2,844,472 | +38.7% | 0.01% | +25.0% |
| Q1 2023 | $76,273,023 | -0.4% | 2,051,453 | +21.4% | 0.01% | -11.1% |
| Q4 2022 | $76,560,805 | +11.0% | 1,689,711 | +71.2% | 0.01% | 0.0% |
| Q3 2022 | $68,943,000 | +13.4% | 987,155 | +9.0% | 0.01% | +12.5% |
| Q2 2022 | $60,784,000 | +489.5% | 905,434 | +622.0% | 0.01% | +700.0% |
| Q1 2022 | $10,311,000 | +163.4% | 125,410 | +369.8% | 0.00% | – |
| Q4 2021 | $3,915,000 | -33.3% | 26,692 | -19.5% | 0.00% | -100.0% |
| Q3 2021 | $5,868,000 | -52.6% | 33,168 | -56.7% | 0.00% | -50.0% |
| Q2 2021 | $12,376,000 | +34.7% | 76,627 | +42.9% | 0.00% | +100.0% |
| Q1 2021 | $9,185,000 | -81.0% | 53,618 | -75.6% | 0.00% | -85.7% |
| Q4 2020 | $48,333,000 | +855.0% | 220,054 | +622.1% | 0.01% | +600.0% |
| Q3 2020 | $5,061,000 | +65.4% | 30,476 | +13.7% | 0.00% | 0.0% |
| Q2 2020 | $3,060,000 | +38.1% | 26,801 | -7.0% | 0.00% | 0.0% |
| Q1 2020 | $2,216,000 | -88.0% | 28,816 | -79.9% | 0.00% | -75.0% |
| Q4 2019 | $18,502,000 | +486.1% | 143,583 | +254.3% | 0.00% | +300.0% |
| Q3 2019 | $3,157,000 | +77.1% | 40,528 | +134.1% | 0.00% | – |
| Q2 2019 | $1,783,000 | +86.5% | 17,310 | +32.7% | 0.00% | – |
| Q1 2019 | $956,000 | -54.5% | 13,044 | -73.7% | 0.00% | -100.0% |
| Q4 2018 | $2,102,000 | -16.4% | 49,540 | -7.2% | 0.00% | 0.0% |
| Q3 2018 | $2,514,000 | +14.6% | 53,375 | +20.0% | 0.00% | 0.0% |
| Q2 2018 | $2,194,000 | +383.3% | 44,487 | +200.6% | 0.00% | – |
| Q1 2018 | $454,000 | +56.6% | 14,797 | -6.7% | 0.00% | – |
| Q4 2017 | $290,000 | -85.1% | 15,857 | -90.5% | 0.00% | -100.0% |
| Q3 2017 | $1,944,000 | +1575.9% | 166,092 | +423.5% | 0.00% | – |
| Q2 2017 | $116,000 | -79.0% | 31,730 | -70.1% | 0.00% | – |
| Q1 2017 | $552,000 | -16.1% | 106,000 | -23.3% | 0.00% | – |
| Q4 2016 | $658,000 | +166.4% | 138,202 | +269.5% | 0.00% | – |
| Q3 2016 | $247,000 | -41.1% | 37,400 | -51.3% | 0.00% | – |
| Q2 2016 | $419,000 | -59.4% | 76,731 | +59.2% | 0.00% | – |
| Q1 2016 | $1,032,000 | -76.9% | 48,203 | -65.9% | 0.00% | -100.0% |
| Q4 2015 | $4,470,000 | -0.6% | 141,460 | +8.3% | 0.00% | 0.0% |
| Q3 2015 | $4,495,000 | +169.6% | 130,587 | +146.5% | 0.00% | +100.0% |
| Q2 2015 | $1,667,000 | +238.1% | 52,970 | +215.1% | 0.00% | – |
| Q1 2015 | $493,000 | -23.3% | 16,811 | -51.6% | 0.00% | – |
| Q4 2014 | $643,000 | +35.7% | 34,736 | +28.6% | 0.00% | – |
| Q3 2014 | $474,000 | +13.1% | 27,006 | +28.9% | 0.00% | – |
| Q2 2014 | $419,000 | -60.2% | 20,945 | -62.1% | 0.00% | – |
| Q1 2014 | $1,054,000 | +567.1% | 55,315 | +482.1% | 0.00% | – |
| Q4 2013 | $158,000 | – | 9,502 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
| ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
| Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
| Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
| Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
| Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
| Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
| RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
| Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |